Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Mortality risk factors associated with familial Mediterranean fever among a cohort of 1.25 million adolescents.

Twig G, Livneh A, Vivante A, Afek A, Shamiss A, Derazne E, Tzur D, Ben-Zvi I, Tirosh A, Barchana M, Shohat T, Golan E, Amital H.

Ann Rheum Dis. 2014 Apr;73(4):704-9. doi: 10.1136/annrheumdis-2012-202932. Epub 2013 Mar 16.

2.

Long-term outcome of renal transplantation in patients with familial Mediterranean fever amyloidosis: a single-center experience.

Abedi AS, Nakhjavani JM, Etemadi J.

Transplant Proc. 2013;45(10):3502-4. doi: 10.1016/j.transproceed.2013.09.021.

PMID:
24314942
3.

Familial Mediterranean fever: risk factors, causes of death, and prognosis in the colchicine era.

Akar S, Yuksel F, Tunca M, Soysal O, Solmaz D, Gerdan V, Celik A, Sen G, Onen F, Akkoc N.

Medicine (Baltimore). 2012 May;91(3):131-6. doi: 10.1097/MD.0b013e3182561a45.

4.

Risk factors for amyloidosis and impact of kidney transplantation on the course of familial Mediterranean fever.

Ben-Zvi I, Danilesko I, Yahalom G, Kukuy O, Rahamimov R, Livneh A, Kivity S.

Isr Med Assoc J. 2012 Apr;14(4):221-4.

5.

Familial Mediterranean fever in children: report of a large series and discussion of the risk and prognostic factors of amyloidosis.

Saatçi U, Ozen S, Ozdemir S, Bakkaloglu A, Besbas N, Topaloglu R, Arslan S.

Eur J Pediatr. 1997 Aug;156(8):619-23.

PMID:
9266193
6.
7.

Renal transplantation in patients with familial Mediterranean fever.

Erdem E, Karatas A, Kaya C, Dilek M, Yakupoglu YK, Arık N, Akpolat T.

Clin Rheumatol. 2012 Aug;31(8):1183-6. doi: 10.1007/s10067-012-1992-6. Epub 2012 May 5.

PMID:
22562368
8.

Serum galectin-3 levels were associated with proteinuria in patients with Familial Mediterranean Fever.

Yilmaz H, Inan O, Darcin T, Bilgic MA, Akcay A.

Clin Exp Nephrol. 2015 Jun;19(3):436-42. doi: 10.1007/s10157-014-1009-7. Epub 2014 Jul 25.

PMID:
25059227
9.

Familial Mediterranean fever (FMF) with proteinuria: clinical features, histology, predictors, and prognosis in a cohort of 25 patients.

Kukuy O, Livneh A, Ben-David A, Kopolovic J, Volkov A, Shinar Y, Holtzman E, Dinour D, Ben-Zvi I.

J Rheumatol. 2013 Dec;40(12):2083-7. doi: 10.3899/jrheum.130520. Epub 2013 Oct 15.

PMID:
24128782
10.

The effect of dialytic modalities on clinical outcomes in ESRD patients with familial Mediterranean fever.

Sahin S, Sahin GM, Ergin H, Kantarci G.

Ren Fail. 2007;29(3):315-9.

PMID:
17497446
11.

[Familial Mediterranean Fever (FMF): from diagnosis to treatment].

Medlej-Hashim M, Loiselet J, Lefranc G, Mégarbané A.

Sante. 2004 Oct-Dec;14(4):261-6. Review. French.

12.

Familial Mediterranean fever during pregnancy: an independent risk factor for preterm delivery.

Ofir D, Levy A, Wiznitzer A, Mazor M, Sheiner E.

Eur J Obstet Gynecol Reprod Biol. 2008 Dec;141(2):115-8. doi: 10.1016/j.ejogrb.2008.07.025. Epub 2008 Sep 3.

PMID:
18771840
13.

AA type renal amyloidosis secondary to FMF: a long-term follow-up in two patients.

Aybal Kutlugün A, Yildirim T, Altindal M, Arici M, Yasavul U, Turgan C.

Ren Fail. 2010;32(10):1230-2. doi: 10.3109/0886022X.2010.517344.

PMID:
20954987
14.

Familial Mediterranean fever (FMF)-associated amyloidosis in childhood. Clinical features, course and outcome.

Cakar N, Yalçinkaya F, Ozkaya N, Tekin M, Akar N, Koçak H, Misirlioğlu M, Akar E, Tümer N.

Clin Exp Rheumatol. 2001 Sep-Oct;19(5 Suppl 24):S63-7.

PMID:
11760404
15.

Dramatic beneficial effect of interleukin-1 inhibitor treatment in patients with familial Mediterranean fever complicated with amyloidosis and renal failure.

Stankovic Stojanovic K, Delmas Y, Torres PU, Peltier J, Pelle G, Jéru I, Colombat M, Grateau G.

Nephrol Dial Transplant. 2012 May;27(5):1898-901. doi: 10.1093/ndt/gfr528. Epub 2011 Sep 19.

PMID:
21931121
17.

Amyloidosis and its related factors in Turkish patients with familial Mediterranean fever: a multicentre study.

Kasifoglu T, Bilge SY, Sari I, Solmaz D, Senel S, Emmungil H, Kilic L, Oner SY, Yildiz F, Yilmaz S, Bakirli DE, Tufan MA, Yilmaz S, Yazisiz V, Pehlivan Y, Bes C, Cetin GY, Erten S, Gonullu E, Temel T, Sahin F, Akar S, Aksu K, Kalyoncu U, Direskeneli H, Erken E, Kisacik B, Sayarlioglu M, Korkmaz C.

Rheumatology (Oxford). 2014 Apr;53(4):741-5. doi: 10.1093/rheumatology/ket400. Epub 2013 Dec 24.

PMID:
24369413
18.

Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study.

Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F, Tutar E, Ozen S, Topaloglu R, Yilmaz E, Arici M, Bakkaloglu A, Besbas N, Akpolat T, Dinc A, Erken E; Turkish FMF Study Group.

Medicine (Baltimore). 2005 Jan;84(1):1-11.

19.

Familial Mediterranean fever at the millennium. Clinical spectrum, ancient mutations, and a survey of 100 American referrals to the National Institutes of Health.

Samuels J, Aksentijevich I, Torosyan Y, Centola M, Deng Z, Sood R, Kastner DL.

Medicine (Baltimore). 1998 Jul;77(4):268-97. Review.

20.

Pregnancy outcome of five patients with renal amyloidosis regarding familial Mediterranean fever.

Turgal M, Selcuk I, Ozyuncu O.

Ren Fail. 2014 Mar;36(2):306-8. doi: 10.3109/0886022X.2013.846863. Epub 2013 Oct 29.

PMID:
24168456

Supplemental Content

Support Center